TTBK2 inhibitors are a class of chemical compounds designed to specifically inhibit the function of tau tubulin kinase 2 (TTBK2), a serine/threonine kinase that plays a crucial role in regulating various cellular processes. TTBK2 is involved in phosphorylating proteins, particularly tubulin and tau, which are key components of the microtubule network within cells. This kinase is also associated with important regulatory functions in cilia assembly, intracellular transport, and cytoskeletal dynamics. TTBK2 inhibitors work by binding to the kinase's active site or allosteric regions, blocking its ability to transfer phosphate groups to its substrate proteins. Inhibiting TTBK2 activity can lead to alterations in cellular signaling pathways and affect the structural stability of the cytoskeleton.
Chemically, TTBK2 inhibitors are typically small molecules with structural features that allow them to fit precisely within the ATP-binding pocket or other critical regions of the enzyme. These inhibitors are often designed to mimic the natural substrates or ATP itself, competing for binding and effectively reducing kinase activity. Specificity is a key factor in the design of TTBK2 inhibitors, as TTBK2 shares structural similarities with other kinases in the serine/threonine kinase family. Thus, researchers focus on developing inhibitors that target unique regions of the TTBK2 protein to minimize cross-reactivity with other kinases. Studying these inhibitors helps to elucidate the precise role of TTBK2 in cellular processes, particularly in microtubule organization and phosphorylation events, providing insights into the broader mechanisms of kinase regulation and cytoskeletal maintenance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
A cyclin-dependent kinase inhibitor that may also inhibit TTBK2 by targeting its kinase domain, potentially affecting tau phosphorylation. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $77.00 $315.00 $658.00 | 1 | |
Known to inhibit various kinases; its broad activity spectrum suggests potential for indirect inhibition of TTBK2. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $60.00 $150.00 $226.00 $495.00 | 1 | |
Inhibits cyclin-dependent kinases and might affect TTBK2 indirectly due to its role in cell cycle regulation and tau protein phosphorylation. | ||||||
Harmine | 442-51-3 | sc-202644 sc-202644A sc-202644B sc-202644C sc-202644D sc-202644E sc-202644F | 250 mg 500 mg 1 g 10 g 50 g 100 g 500 g | $52.00 $102.00 $124.00 $540.00 $1438.00 $2560.00 $11230.00 | 2 | |
A dual-specificity tyrosine phosphorylation-regulated kinase inhibitor, which may also affect TTBK2 activity indirectly. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $150.00 $455.00 | 20 | |
An adenosine kinase inhibitor that could indirectly impact TTBK2 signaling pathways through modulation of cellular adenosine levels. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
A checkpoint kinase inhibitor that potentially impacts pathways related to TTBK2's role in DNA damage response and cell cycle control. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $193.00 $510.00 $1072.00 | 4 | |
A receptor tyrosine kinase inhibitor that might influence TTBK2 activity indirectly through its broad spectrum of kinase inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that could affect TTBK2 indirectly by altering downstream signaling pathways involved in cell survival and metabolism. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor potentially affecting signaling pathways that intersect with TTBK2's role in cellular stress responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor that might indirectly modulate TTBK2 activity through pathways involved in inflammation and stress response. | ||||||